Cucurbitacin B attenuates osteoarthritis development by inhibiting NLRP3 inflammasome activation and pyroptosis through activating Nrf2 / HO ‐1 pathway
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Chao Lou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NF-E2-Related Factor 2, Osteoarthritis, Triterpenes. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Basic Public Welfare Research Project of Zhejiang Province, Zhejiang Medicine Health Science and Technology Program, Wenzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Osteoarthritis (OA) is a complicated joint disorder characterized by inflammation that causes joint destruction. Cucurbitacin B (CuB) is a naturally occurring triterpenoid compound derived from plants in the Cucurbitaceae family. The aim of this study is to investigate the potential role and mechanisms of CuB in a mouse model of OA. This study identified the key targets and potential pathways of CuB through network pharmacology analysis. In vivo and in vitro studies confirmed the potential mechanisms of CuB in OA. Through network pharmacology, 54 potential targets for CuB in treating OA were identified. The therapeutic potential of CuB is associated with the nod‐like receptor pyrin domain 3 (NLRP3) inflammasome and pyroptosis. Molecular docking results indicate a strong binding affinity of CuB to nuclear factor erythroid 2‐related factor 2 (Nrf2) and p65. In vitro experiments demonstrate that CuB effectively inhibits the expression of pro‐inflammatory factors induced by interleukin‐1β (IL‐1β), including cyclooxygenase‐2, inducible nitric oxide synthase, IL‐1β, and IL‐18. CuB inhibits the degradation of type II collagen and aggrecan in the extracellular matrix (ECM), as well as the expression of matrix metalloproteinase‐13 and a disintegrin and metalloproteinase with thrombospondin motifs‐5. CuB protects cells by activating the Nrf2/hemeoxygenase‐1 (HO‐1) pathway and inhibiting nuclear factor‐κB (NF‐κB)/NLRP3 inflammasome‐mediated pyroptosis. Moreover, in vivo experiments show that CuB can slow down cartilage degradation in an OA mouse model. CuB effectively prevents the progression of OA by inhibiting inflammation in chondrocytes and ECM degradation. This action is further mediated through the activation of the Nrf2/HO‐1 pathway to inhibit NF‐κB/NLRP3 inflammasome activation. Thus, CuB is a potential therapeutic agent for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Wenzhou Medical University, Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, China.
- Department of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Wei Hu, Liaojun Sun, Hua Chen, Wenhao Zheng
Förderung
- Basic Public Welfare Research Project of Zhejiang Province
- Zhejiang Medicine Health Science and Technology Program
- Wenzhou Science and Technology Plan Project
- Science and Technology Plan Project of Wenzhou Municipality
Zitieren
APA
Lou, C., Fang, Y., Mei, Y., Hu, W., Sun, L., Jin, C., Chen, H., & Zheng, W. (2024). Cucurbitacin B attenuates osteoarthritis development by inhibiting NLRP3 inflammasome activation and pyroptosis through activating Nrf2 / HO ‐1 pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.8209
Vancouver
Lou C, Fang Y, Mei Y, Hu W, Sun L, Jin C, et al. Cucurbitacin B attenuates osteoarthritis development by inhibiting NLRP3 inflammasome activation and pyroptosis through activating Nrf2 / HO ‐1 pathway. Phytotherapy Research. 2024. doi:10.1002/ptr.8209
BibTeX
@article{Lou2024,
author = {Lou, Chao and Fang, Yuqin and Mei, Yifan and Hu, Wei and Sun, Liaojun and Jin, Chen and Chen, Hua and Zheng, Wenhao},
title = {Cucurbitacin B attenuates osteoarthritis development by inhibiting NLRP3 inflammasome activation and pyroptosis through activating Nrf2 / HO ‐1 pathway},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8209}
}
EUVIMED